Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
Stay current with insights from our analysts and industry updates. We also offer customised newsletters to keep your management, sales and marketing teams fully informed - contact us to find out more.
06-Apr-17 Natali, Israel's largest private healthcare provider, became a subsidiary of China's Sanpower group in 2014. Since then they have implemented their eHealth/TeleHealth technologies in the Chinese market, amassing 120,000 Israeli subscribers and over 4 mn in China. When asked about the Chinese healthcare market, Nimrod Altman, CEO of Natali Healthcare Group , noted "Barriers are collapsing". [image: PRNewsFoto / Natali Healthcare Group]
Read More
06-Apr-17 Global healthcare spending is roughly USD7 tn, according to the US Department of Commerce and many companies would have more success pursuing product approval in emerging markets as the technologies may be more helpful for those patient populations and the regulatory burdens more manageable, suggested Matthew Hein, representative for the US DoC at the MedTech Intelligence Global Regulatory conference. [image: MedTech Intelligence]
Read More
06-Apr-17 Korea's medical institutions expanded their businesses into 20 countries during 2016, according to a report by the Ministry of Health & Welfare. During 2016, Korean medical institutions continued their spread of the medicalss "Korean wave”, entering countries including China, the USA, Vietnam, Kazakhstan, and the UAE as well as many others, three more countries than in 2015. [image: Business Korea]
Read More
06-Apr-17 Korean company SK Holdings C&C has opened an AI cancer medical centre providing medical treatment through IBM's Watson for Oncology with Kunyang University Hospital. The AI service provided by Watson for oncology allows patients to receive cancer treatments at international standards proven around the world, without leaving their home. [image: Business Korea]
Read More
06-Apr-17 In Japanese companies' largest study to date, Takeda will test an experimental dengue vaccine on 20,100 children and adolescents in eight countries in Latin America. Takeda said it has completed enrollment for a 20,000-subject dengue vaccine trial, the largest clinical study in its history, signalling the global ambitions of its vaccine business. [image: ET Healthworld]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: